Patents Assigned to GLYCOPROBE AB
  • Patent number: 12582754
    Abstract: A kit for reduction of blood components in a blood-related medium (12) is disclosed, wherein it comprises a gel bead container (1) containing gel beads (2) and provided with an outlet tube (3), a drip chamber (4) provided with an inlet tube (5) and an outlet tube (6), a collection container (10) provided with an inlet tube (11), and a medium container (13) adapted to contain a blood-related medium (12) and provided with an outlet tube (15), wherein the outlet tube (3) of the gel bead container (1) is connectable with the inlet tube (5) of the drip chamber (4) via a sterile connecting device, wherein the outlet tube (6) of the drip chamber is connectable with the inlet tube (11) of the collection container (10) via a sterile connecting device, and wherein the outlet tube (15) of the medium container (13) is connectable to the inlet tube (5) of the drip chamber (4) via a sterile connecting device, as well as a method for reduction of blood components in a blood-related medium (12) by use of said kit.
    Type: Grant
    Filed: May 6, 2021
    Date of Patent: March 24, 2026
    Assignee: GLYCOPROBE AB
    Inventor: Kurt Nilsson
  • Patent number: 12458950
    Abstract: An adsorbent comprising at least two types of covalently bound antigens having the ability to bind at least one component present in a blood flow or blood plasma flow passing through said adsorbent is disclosed, as well as a column containing said adsorbent, a kit containing said column in a sealed plastic bag, a method for the production of said kit, a method for reduction or elimination of undesired blood group specific antibodies or autoimmune antibodies in connection with autoimmune diseases, a method for treatment of myasthenia gravis, and a method for treatment of rheumatoid arthritis.
    Type: Grant
    Filed: October 29, 2020
    Date of Patent: November 4, 2025
    Assignee: GLYCOPROBE AB
    Inventor: Kurt Nilsson
  • Publication number: 20230355849
    Abstract: A kit for reduction of blood components in a blood-related medium (12) is disclosed, wherein it comprises a gel bead container (1) containing gel beads (2) and provided with an outlet tube (3), a drip chamber (4) provided with an inlet tube (5) and an outlet tube (6), a collection container (10) provided with an inlet tube (11), and a medium container (13) adapted to contain a blood-related medium (12) and provided with an outlet tube (15), wherein the outlet tube (3) of the gel bead container (1) is connectable with the inlet tube (5) of the drip chamber (4) via a sterile connecting device, wherein the outlet tube (6) of the drip chamber is connectable with the inlet tube (11) of the collection container (10) via a sterile connecting device, and wherein the outlet tube (15) of the medium container (13) is connectable to the inlet tube (5) of the drip chamber (4) via a sterile connecting device, as well as a method for reduction of blood components in a blood-related medium (12) by use of said kit.
    Type: Application
    Filed: May 6, 2021
    Publication date: November 9, 2023
    Applicant: GLYCOPROBE AB
    Inventor: Kurt NILSSON
  • Publication number: 20230302429
    Abstract: An adsorbent comprising at least two types of covalently bound antigens having the ability to bind at least one component present in a blood flow or blood plasma flow passing through said adsorbent is disclosed, as well as a column containing said adsorbent, a kit containing said column in a sealed plastic bag, a method for the production of said kit, a method for reduction or elimination of undesired blood group specific antibodies or autoimmune antibodies in connection with autoimmune diseases, a method for treatment of myasthenia gravis, and a method for treatment of rheumatoid arthritis.
    Type: Application
    Filed: October 29, 2020
    Publication date: September 28, 2023
    Applicant: GLYCOPROBE AB
    Inventor: Kurt NILSSON